BioCryst Pharmaceuticals ... (BCRX)
NASDAQ: BCRX
· Real-Time Price · USD
8.72
-0.13 (-1.47%)
At close: May 01, 2025, 3:59 PM
8.61
-1.26%
After-hours: May 01, 2025, 07:49 PM EDT
BioCryst Pharmaceuticals Analyst Ratings
Total Analysts
8
Consensus Rating
Buy
Price Target
15
Upside
72.02
Ratings History
| Analyst | Firm | Rating | Action | Price Target | Upside | Date |
| Cantor Fitzgerald | Buy | Initiates | 20 | 129.36% | Apr 29, 2025 | |
| RBC Capital | Buy | Initiates | 11 11 | 26.15% | Apr 11, 2025 | |
| Needham | Buy | Reiterates | 15 15 | 72.02% | Apr 10, 2025 |
Stop Guessing, Start Knowing.
Cut through market noise with actionable insights that actually help you make confident investment decisions. No more endless research or gut-based guessing.
- Unlimited access to all data and tools
- Unlimited access to all data and tools, giving you the edge over everyone else in the market.
- Realtime Options & Dark Pool Data
- Instant access to live options & dark pool data to spot opportunities and trade with precision before the market moves.
- Top Wallstreet Analyst Ratings
- Follow ratings from the best analysts on Wall Street to stay ahead.
- Up to 30 years financial history
- We deliver premium Wall Street data with top-tier accuracy and up to 30 years of history.
Analyst Star Rankings
Our analyst star rankings are based on these four factors
- Success Rate
- The percentage of ratings that are profitable.
- Average Return
- The average percentage return within one year of the rating.
- Rating Count
- The more ratings the analyst has provided, the higher the score.
- Recency
- Ratings provided within the past year contribute to a higher score.